Physician profile
Jared Jamieson Ebert
NPI 1790244572
$6,151.03
in general payments reported to CMS, 2019-2025
20 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.95 · 2020: $154 · 2021: $657 · 2022: $876 · 2023: $1,639 · 2024: $1,765 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955 · Honoraria: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,955.35 |
| Honoraria | $460.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,828.48 | 2019-2025 | Constellation, Ngenuity, Hydrus Microstent |
| Alimera Sciences, INC. | $609.71 | 2024 | Iluvien, Yutiq |
| Abbvie INC. | $464.00 | 2023-2025 | Ozurdex |
| Apellis Pharmaceuticals, INC. | $426.93 | 2022-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $284.82 | 2022-2025 | Stellaris, Stellaris, Xipere |
| Glaukos Corporation | $235.19 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $212.19 | 2022-2024 | Eylea Hd |
| Eyepoint US, INC. | $201.32 | 2023 | |
| Ani Pharmaceuticals, INC. | $146.96 | 2025 | Purified Cortrophin Gel, Iluvien |
| Allergan, INC. | $146.27 | 2020-2021 | |
| Sight Sciences, INC. | $130.11 | 2023 | Omni Surgical System |
| Horizon Therapeutics Plc | $120.93 | 2021 | |
| Coherus Oncology, INC. | $76.14 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $69.49 | 2023-2024 | Tecnis Simplicity, Amo Phaco Needle |
| Haag-Streit USA, INC. | $59.46 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $42.94 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $27.89 | 2023 | Forum |
| Astellas Pharma US INC | $26.49 | 2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.01 | 2021 | |
| Spark Therapeutics, INC. | $20.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Ebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.